Table 3.
The results of the multivariate Cox regression analysis.
| Variable | PFS | OS | ||
|---|---|---|---|---|
| HR (95%CI) | P | HR (95%CI) | P | |
| Gender | 2.394 (1.086-5.276) | 0.030* | NS | |
| PD-L1 50% | NA | NA | NS | |
| TNM | NS | NA | NA | |
| Pathology | NS | NA | NA | |
| Smoke | 4.989 (2.098-11.860) | <0.001* | 5.507 (1.280-23.697) | 0.022* |
| Treatment | NS | NA | NA | |
| Metastasis | 1.949 (1.127-3.371) | 0.017* | 8.785 (3.632-21.248) | <0.001* |
| Ki-67 | NS | NA | NA | |
| LN | 2.185 (0.984-4.855) | 0.045 | NS | |
| SUVmax | NS | NS | ||
| MTV | NS | NS | ||
| TLG (mL) | NS | NS | ||
| Rad-score | 0.1952 (0.045-0.855) | 0.030* | 0.344(0.150-0.792) | 0.012* |
HR, hazard ratio; LN lymph node; SUVmax, standardized uptake value max; MTV, total metabolic tumor volume; TLG, total lesion glycolysis.
NS, not significant; NA, not apply.
*P < 0.05.